Glioz 250 mg Capsules belongs to a class of medicines called 'anti-cancer/ antitumor agent', used to treat specific forms of brain tumours such as glioblastoma multiforme (a type of tumour that grows and spreads rapidly) in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma (a rare malignant brain tumour) in patients older than 3years. A brain tumour is an uncontrolled and unregulated proliferation of cells in the brain. 

Glioz 250 mg Capsules contains Temozolomide which works by inhibiting the production of DNA (deoxyribonucleic acid-genetic material of the cell), thereby affecting cell growth and division. Thus, Glioz 250 mg Capsules prevents tumours from growing.

Take Glioz 250 mg Capsules as prescribed. In some cases, Glioz 250 mg Capsules may cause loss of appetite, anxiety, confusion, headache, vomiting, nausea, diarrhoea, constipation, muscle weakness, muscle aches, and fever. Most of these side effects of Glioz 250 mg Capsules do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Let your doctor know if you are allergic to any of the contents. Glioz 250 mg Capsules is not recommended for patients with severe bone marrow depression or significant bleeding. Avoid taking Glioz 250 mg Capsules if you are pregnant or breastfeeding. Both women and men using Glioz 250 mg Capsules should use birth control to avoid pregnancy and fathering a child. It would be best not to drive and/or operate machines that require alertness as Glioz 250 mg Capsules may cause tiredness or sleepiness.

Glioz 250 mg Capsules belongs to a class of medicines called anti-cancer/antitumor agents used to treat specific forms of brain tumours such as glioblastoma multiforme (a type of tumour that grows and spreads rapidly) in adults and malignant glioma, including glioblastoma multiforme or anaplastic astrocytoma (a rare malignant brain tumour) in patients older than 3years. It contains Temozolomide which works by binding to the DNA (deoxyribonucleic acid-genetic material of the cell) and interfering with cell growth and division. Thus, Glioz 250 mg Capsules prevents tumours from growing.

Glioz 250 mg Capsules should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking Glioz 250 mg Capsules. To treat your condition effectually, continue taking Glioz 250 mg Capsules for as long as your doctor has prescribed. Do not stop Glioz 250 mg Capsules midway under any circumstances without consulting the healthcare professional. Inform your doctor if you have an allergy to any components of Glioz 250 mg Capsules. Inform your doctor before taking Glioz 250 mg Capsules if you have allergic reactions, infections, lung, renal or hepatic disorders or low blood count (including neutropenia, lymphopenia, thrombocytopenia). Glioz 250 mg Capsules is not recommended for patients with severe bone marrow depression or significant bleeding. Avoid taking Glioz 250 mg Capsules if you are pregnant or breastfeeding. Both women and men using Glioz 250 mg Capsules should use birth control to avoid pregnancy or fathering a child. Do not receive any vaccinations or immunizations without your doctor's approval while taking Glioz 250 mg Capsules.

• Glioz 250 mg Capsules should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking Glioz 250 mg Capsules.
• Your doctor may advise you to get routine blood tests done to monitor your liver function, electrolyte levels, and blood cell count.
• Both male and female patients who are taking Glioz 250 mg Capsules must use effective contraceptive precautions. Women of childbearing potential must use effective contraception during the treatment and for 6months after completion of the treatment. Male patients should avoid fathering a child while on treatment with Glioz 250 mg Capsules and should use effective contraception during the treatment and for 3months after the treatment.